PAVmed Stock Quote PAVM - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

1.85

Bid

1.85

Ask

1.87

Volume

16,103

1.84 Day's Range 1.8595

1.60 52 Week Range 9.00

Market Cap

14.894M

Previous Close

1.87

Open

1.84

Last Trade

100

1.85

Last Trade Time

11:11:53

Financial Volume

$ 29,785

VWAP

1.8496

Average Volume (3m)

64,460

Shares Outstanding

8,050,659

Dividend Yield

PE Ratio

-0.22

Earnings Per Share (EPS)

-8.23

Revenue

2.45M

Net Profit

-66.27M

PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others. PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others.

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.pavmed.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

PAVmed Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker PAVM. The last closing price for PAVmed was $1.87. Over the last year, PAVmed shares have traded in a share price range of $ 1.60 to $ 9.00.

PAVmed currently has 8,050,659 shares outstanding. The market capitalization of PAVmed is $14.89 million. PAVmed has a price to earnings ratio (PE ratio) of -0.22.

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference PR Newswire NEW YORK, April 8, 2024 NEW YORK, April 8, 2024 /PRNewswire/ -- Lucid...

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results PR Newswire NEW YORK, March 26, 2024 Lucid's quarterly revenue increased 33 percent sequentially Launched...

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire NEW YORK, March 21...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.03	-1.59574468085	1.88	2.01	1.81	29258	1.90953367	CS
4	-0.47	-20.2586206897	2.32	2.84	1.81	70475	2.28097774	CS
12	-0.48	-20.6008583691	2.33	3.5	1.6	64460	2.30266626	CS
26	-2.44	-56.8764568765	4.29	4.875	1.6	181472	3.48767905	CS
52	-5.9695	-76.3411982863	7.8195	9	1.6	391995	5.18593634	CS
156	-69.1	-97.3925299507	70.95	145.5	1.6	1084586	47.32908491	CS
260	-16.75	-90.0537634409	18.6	145.5	1.6	1177395	47.22246384	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.3871 (154.17%)	98.21M
PREPrenetics Global Ltd	$ 7.38 (61.49%)	1.49M
BOFBranchOut Food Inc	$ 1.85 (58.12%)	59.51M
AMSTAmesite Inc	$ 3.1235 (56.18%)	60.28M
TROOTROOPS Inc	$ 1.5863 (45.53%)	4.82M
GCTKGlucoTrack Inc	$ 0.451 (-40.66%)	922.02k
EVOEvotec SE	$ 5.125 (-33.01%)	685.16k
ATXIAvenue Therapeutics Inc	$ 0.0958 (-28.51%)	6.81M
TSDDGraniteShares ETF Trust GraniteShares	$ 27.6004 (-22.25%)	497.78k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 43.50 (-22.21%)	1.86M
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.3871 (154.17%)	98.21M
TSLATesla Inc	$ 160.955 (11.25%)	91.94M
AMSTAmesite Inc	$ 3.1235 (56.18%)	60.28M
BOFBranchOut Food Inc	$ 1.85 (58.12%)	59.51M
SQQQProShares UltraPro Short QQQ	$ 11.8001 (-0.92%)	51.15M